Serum YKL-40 levels in patients with multiple sclerosis

Dönder, Ahmet; Özdemir, Hasan Hüseyin.
Arq. neuropsiquiatr ; 79(9): 795-798, Sept. 2021. tab
Artículo en Inglés | LILACS | ID: biblio-1345345

Documentos relacionados

  1. Serum YKL-40 levels in patients with multiple sclerosis.
  2. Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosis.
  3. Chitinase-3-like Protein 1 (YKL-40): A New Biomarker of Inflammation in Pyoderma Gangrenosum.
  4. Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection.
  5. Genetic and epigenetic regulation of YKL-40 in childhood.
  6. Association between YKL-40 and asthma: a systematic meta-analysis.
  7. Can YKL-40 be an Inflammatory Biomarker in Vitamin D Deficiency?
  8. Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study.
  9. Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen.
  10. Diagnostic value of YKL-40 for patients with asthma: A meta-analysis.